Long-Listed Products Not Granted Premium Should Be Exempted from New Rule: FPMAJ’s Kamoya

Yoshiaki Kamoya, Chairman of the NHI Drug Price Study Committee, FPMAJ Yoshiaki Kamoya, chairman of the NHI Drug Price Study Committee of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ), on December 7 indicated, as his personal opinion, that...read more